Task-oriented Training on Hand Function in Taxanes-induced Peripheral Neuropathy
1 other identifier
interventional
60
1 country
1
Brief Summary
Chemotherapy based on taxanes is commonly used to treat breast cancer. However, chemotherapy-induced peripheral neuropathy (CIPN), a side effect of taxanes, impairs a patient's grip strength, hand dexterity, and upper extremity function which affects quality of life (QOL).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 9, 2024
CompletedOctober 18, 2024
October 1, 2024
7 months
October 7, 2024
October 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Hand grip strength
Hand grip strength (HGS) was measured in the dominant hand for each patient using The CAMRY dynamometer
At baseline and after four weeks of intervention.
Hand dexterity
The nine-hole peg test was used to assess the hand dexterity
At baseline and after four weeks of intervention.
Hand function
Each patient was asked to answer the questions of the six scales in the Arabic version of Michigan hand questionnaire (1- Overall hand function, 2-Activities of Daily Living, 3- Work performance, 4- Pain, 5- Aesthetics, and 6- Satisfaction with hand function)
At baseline and after four weeks of intervention.
Study Arms (2)
Task oriented training group
EXPERIMENTALThis group included 30 patients suffering from taxanes induced peripheral neuropathy who received 30 minutes of task-oriented exercises, three sessions per week for four weeks along with 30 minutes of the traditional physical therapy.
Traditional physical therapy group
ACTIVE COMPARATORThis group included 30 patients suffering from taxanes induced peripheral neuropathy who received 30 minutes of the traditional physical therapy only, three sessions per week for four weeks.
Interventions
Task oriented training is a type of exercises in form of tasks using papers, pens, scissors, clips, coins, screws and clay
Traditional physical therapy inform of mobilization, strengthening exercises of hand and streching exercises.
Eligibility Criteria
You may qualify if:
- Patients were females only.
- Their ages range from 35 to 65.
- All patients suffered from CIPN after using taxanes (anti-cancer agent causing neurotoxic effect).
- Diagnosis of CIPN was determined based on symptom history or the presence of stocking glove pattern "distal dysesthesias, pain and numbness" beginning after taxanes intake.
- All patients enrolled to the study had their informed consent.
- Patients suffer from affected brachial plexus.
You may not qualify if:
- Patients had pain or numbness in the upper extremity due to other reasons like trauma (fracture), CNS diseases (cerebral infarction), other diseases with neurological symptoms like (diabetes, rheumatoid arthritis or cervical myelopathy).
- Patients had bone, brain or spinal cord metastases.
- Patients who had history of psychiatric disorders like: depression and schizophrenia or cognitive decline that may hinder them from active participation in the study.
- Patients exhibited only acute neuropathy like in patients using oxaliplatin.
- Patients had pain or numbness in the upper extremity due to other reasons like trauma (fracture), CNS diseases (cerebral infarction), other diseases with neurological symptoms like (diabetes, rheumatoid arthritis or cervical myelopathy).
- Patients had bone, brain or spinal cord metastases.
- Patients who had history of psychiatric disorders like: depression and schizophrenia or cognitive decline that may hinder them from active participation in the study.
- Patients exhibited only acute neuropathy like in patients using oxaliplatin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
faculty of physical therapy, Cairo university
Giza, 11432, Egypt
Related Publications (2)
Andersen Hammond E, Pitz M, Shay B. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment. Neurorehabil Neural Repair. 2019 Oct;33(10):792-799. doi: 10.1177/1545968319860486. Epub 2019 Jul 25.
PMID: 31342880BACKGROUNDAndersen Hammond E, Pitz M, Steinfeld K, Lambert P, Shay B. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Neurorehabil Neural Repair. 2020 Mar;34(3):235-246. doi: 10.1177/1545968319899918. Epub 2020 Jan 24.
PMID: 31976819BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shaimaa M A Elsayeh, PhD
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical Therapy Specialist
Study Record Dates
First Submitted
October 7, 2024
First Posted
October 9, 2024
Study Start
September 1, 2023
Primary Completion
April 1, 2024
Study Completion
June 1, 2024
Last Updated
October 18, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share